0.3125EUR
53.34 MEUR
337.73 MEUR
27.93 M
About SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD.
Sector
Industry
CEO
Jian Ying Wu
Website
Headquarters
Shanghai
Employees (FY)
2.16 K
Founded
2007
ISIN
CNE100001W69
FIGI
BBG008LYF043
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, production and sales of medical devices and pharmaceuticals. It offers orthopedics, medical aesthetics, wound healing, hemostasis, ophthalmology and anti-adhesion products. The company mainly offers intraocular lens (IOL), ophthalmology and optometry end products, medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF amd other related products. Shanghai Haohai Biological Technology was founded on January 24, 2007 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. stocks are traded under the ticker 5HB.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. has a max estimate of 14.6430 EUR and a min estimate of 12.1895 EUR.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. revenue for the last quarter amounts to 88.73 M EUR despite the estimated figure of 84.68 M EUR. In the next quarter revenue is expected to reach 85.75 M EUR.
Yes, you can track SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. financials in yearly and quarterly reports right on TradingView.
5HB net income for the last quarter is 11.20 M EUR, while the quarter before that showed 15.85 M EUR of net income which accounts for −29.34% change. Track more SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. financial stats to get the full picture.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. dividend yield was 2.48% in 2023, and payout ratio reached 37.09%. The year before the numbers were 1.20% and 36.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 5HB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 2.16 K employees. See our rating of the largest employees — is SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. on this list?
We've gathered analysts' opinions on SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. future price: according to them, 5HB price has a max estimate of 14.64 EUR and a min estimate of 12.19 EUR. Read a more detailed SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. forecast: see what analysts think of SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. EBITDA is 76.54 M EUR, and current EBITDA margin is 22.63%. See more stats in SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. financial statements.